This section presents medications that are known to potentially lead to 'Anginal attack' as a side effect. It's important to note that mild side effects are quite common with medications. Please be ...

WE first became interested in the possibility of relieving anginal pain in patients undergoing splanchnicectomy who had severe hypertension and angina pectoris. After the pioneer work of White, 1 who ...

Chest pain due to a shortage of blood in the heart, known as angina, is a condition that affects millions of Americans. The most recently approved new pharmaceutical approach to treat chronic angina ...

THE symptoms accompanying paroxysmal tachycardia are numerous and varied. Most of them are not caused directly by the tachycardia, nor are they directly or specifically related to the underlying heart ...

Please provide your email address to receive an email when new articles are posted on . The study included data on 32,691 patients with stable CAD from the prospective, observational CLARIFY registry.

The anti-anginal medication ranolazine was shown to be safe in regard to certain outcomes but did not reduce the risk of major cardiovascular events such as death, heart attack or recurrent ischemia ...

FDA Approves CV Therapeutics, Inc Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial ...

Objective: To evaluate the effects of moderate weight loss, in overweight patients with angina, on plasma coagulation, fibrinolytic indicies and pain frequency. Design: Single-stranded 12-week dietary ...

Background: Reference-based pricing limits reimbursement for a group of drugs that are deemed therapeutically equivalent to the cost of the lowest-priced product within that group. We estimated the ...

Despite being safe, anti-anginal medication Ranolazine has not been effective in reducing the risk of major cardiovascular events such as death , heart attack or recurrent ischemia following acute ...